Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Comment by narcissiston Feb 02, 2012 10:52am
267 Views
Post# 19479472

RE: RE: well well

RE: RE: well well

Freeda, a pollyanna is blindly optimistic - irrationally so. A Casandra is a prophet whose prophesies are never believed. A sceptic takes ISA spin and re-expresses it like it is. I think the pollyanna description would fit if voclosporin was clearly a marginal drug with no promise. But clearly it is not. It does work and it MAY be much safer than current regimens and furthermore there is nothing in the pipe to rival voclosporin. As for spin, I am tring to work around corporate double speak (and I agree there is much of that) by going back to the data - the peer-reviewed journal articles on the independent research done on voclosporin for all of the indications - transplant, uveitis, lupus, psoriasis, etc. Those articles are all that I really have to go by. And each time I do go back to re-read those studies, I return to the same inescapable conclusion: this drug shows enormous promise. There's nothing flaky in the chemistry, or in the ways those studies were done. But everything in the future depends on a phase 3 Clinical trial - a trial that I am willing to bet - based on the science, and on the science alone - will produce favorable results. That's why I continue to hold the stock.  That trial could go South - in which case ISA and voclosporin are finished. But until that happens I remain optimistic. I love scepticism and enjoy reading those posts that reflect doubts about the future. Sometimes I am even persuaded that this whole business is another corporate scam. But then I go back to the science again, and recall that it just can't be so. it's awfully difficult for a small Canadian Pharma with no track record to rig those results. What I do find annoying are the crank poster boys. Those who profusely use CAPITOL LETTERS to draw my attention, or engage in bullying tactics to intimidate. I had my fill of bullies and other cowards in my school boy years. They are all losers, and those not in jail are serving out there final years on psychotropic drugs. On those sorts of contributors I rather prefer to follow Napoleon's advice (advice his own enimies eventually learned): "Never interrupt your enemy while he's making a mistake." :)

"

<< Previous
Bullboard Posts
Next >>